BBIO
#668
BridgeBio Pharma, Inc. - Common Stock
81.7 4 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.83%
Monthly Change
+20.97%
6 month change
+7.38%
Year Change
+43.40%
Previous Close
85.8 9
Open
81.4 3
Low
81.4 3
High
81.9 5
Volume
768
Financials
- Market Capitalization 16.01 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.24
Price to sales ratio
29.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 576 |  BNTX BioNTech SE - American Depositary Shares | 89.71 USD | -1.95% | -5.33% | +0.68% | -19.30% | 21.53 B USD | ||
| 659 |  ASND Ascendis Pharma A/S - American Depositary Shares | 264.28 USD | -2.28% | -2.18% | +18.82% | +28.87% | 16.38 B USD | ||
| 711 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 236.37 USD | -3.06% | -2.62% | +0.40% | +68.84% | 14.83 B USD | ||
| 734 |  EXEL Exelixis, Inc. - Common Stock | 55.89 USD | -1.08% | +0.65% | +4.47% | +43.16% | 14.05 B USD |
Frequently asked questions about BridgeBio Pharma, Inc. - Common Stock
What is the BridgeBio Pharma, Inc. - Common Stock stock price today?
The current price of BridgeBio Pharma, Inc. - Common Stock (BBIO) is 81.74. Over the past 24 hours, the stock has changed by -4.83%. Follow the BBIO chart for real-time price dynamics.
What is the stock ticker of BridgeBio Pharma, Inc. - Common Stock?
BridgeBio Pharma, Inc. - Common Stock trades under the ticker BBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BridgeBio Pharma, Inc. - Common Stock stock going up?
BBIO has changed by +3.89% over the last week, +20.97% over the last month, and +43.40% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BridgeBio Pharma, Inc. - Common Stock net income for the last quarter?
BridgeBio Pharma, Inc. - Common Stock reported net income of -166.56 M for the last quarter. The previous quarter showed -194.63 M, which means net income changed by +14.43%.
How many employees does BridgeBio Pharma, Inc. - Common Stock have?
As of the latest available data, BridgeBio Pharma, Inc. - Common Stock has 839 employees. Workforce size can provide additional context about the company's scale and operations.
What is BridgeBio Pharma, Inc. - Common Stock EBITDA?
BridgeBio Pharma, Inc. - Common Stock EBITDA is -104.77 M, and its EBITDA margin is -53.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BridgeBio Pharma, Inc. - Common Stock stock?
You can buy BridgeBio Pharma, Inc. - Common Stock (BBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BridgeBio Pharma, Inc. - Common Stock stock?
Investing in BridgeBio Pharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBIO chart and related analysis on metatrader.com as part of your research.